デフォルト表紙
市場調査レポート
商品コード
1464130

医療向けバイオミメティックスの世界市場レポート 2024年

Medical Biomimetics Global Market Report 2024

出版日: | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=153.40円
医療向けバイオミメティックスの世界市場レポート 2024年
出版日: 2024年04月17日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

医療向けバイオミメティックスの市場規模は、今後数年間で安定した成長が見込まれます。2028年の年間平均成長率(CAGR)は6.8%で、476億9,000万米ドルに成長します。予測期間の成長は、臓器移植需要の増加、ヘルスケアにおけるバイオミメティクス応用に対する意識の高まり、ヘルスケア支出の増加、バイオテクノロジー分野の拡大、組織工学の進歩などの要因によって牽引されると予想されます。予測期間の主な動向には、バイオインスパイアされた人工装具、バイオミメティック・センサー、合成生物学の応用、スマート・ドラッグデリバリー・システム、生物学的にインスパイアされたロボット工学、個別化医療、3Dプリンティング技術の活用、診断における人工知能、ナノテクノロジーの応用、再生医療の発展などが含まれます。

肥満と心臓病率の増加が予想され、医療向けバイオミメティックス市場の成長を牽引すると期待されています。余分な体脂肪の蓄積を特徴とする肥満と、心臓や血管に影響を及ぼす様々な症状を包含する心臓病は、革新的なソリューションの必要性を促しています。医療向けバイオミメティックスは、糖尿病や肥満などの症状を管理する個人向けの装具や義肢などの補助器具の開発に重要な役割を果たしています。2022年5月、米国疾病予防管理センターは、米国における重度の肥満が大幅に増加し、4.7%から2021年には9.2%に達したと報告しました。特に、20歳から39歳の成人の肥満率は39.8%で、40歳から59歳の肥満率は44.3%でした。さらに、英国国家統計局が2022年3月に発表した報告書では、心臓病関連死が2020年の19,440人から2021年には20,061人に増加することが強調されています。肥満と心臓病の増加率は、医療向けバイオミメティックス市場の主要促進要因です。

医療向けバイオミメティックス分野の大手企業は、先進技術を搭載した革新的な製品に戦略的に投資しています。特に、縫合糸アンカーシステムの開発は重要な進歩として際立っています。この医療機器は整形外科やスポーツ医学の処置に使用され、腱や靭帯などの軟部組織を骨に固定します。縫合糸アンカーシステムは、軟部組織と骨との自然な結合を模倣し、強化することを目的としており、生理的な組織結合を反映した生体力学的に最適化されたソリューションを提供します。2022年12月、米国の多国籍医療技術企業であるStryker Corporationは、クエン酸ポリマーから作られたエラストマー材料であるCitregenから作られた再吸収可能な生体模倣型アンカー本体を組み込んだ使い捨て縫合糸アンカーシステムであるCitrefixを発売しました。このデザインは、慢性炎症を誘発することなく、制御された再吸収を促進し、整形外科の外科的用途における貴重なツールとなっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界の市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年~2023年
  • 世界の市場規模予測と成長、2023年~2028年、2033年

第6章 市場セグメンテーション

  • 世界の医療向けバイオミメティックス市場:タイプ別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 心臓血管
  • 整形外科
  • 眼科
  • 歯科
  • その他のタイプ
  • 世界の医療向けバイオミメティックス市場:用途別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 創傷治癒
  • ヒト組織工学
  • ドラッグデリバリー
  • その他の用途
  • 世界の医療向けバイオミメティックス市場:エンドユーザー別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 病院
  • 専門クリニック
  • その他のエンドユーザー

第7章 地域別・国別分析

  • 世界の医療向けバイオミメティックス市場:地域別、実績と予測, 2018-2023, 2023-2028F, 2033F
  • 世界の医療向けバイオミメティックス市場:国別、実績と予測, 2018-2023, 2023-2028F, 2033F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 医療向けバイオミメティックス市場:競合情勢
  • 医療向けバイオミメティックス市場:企業プロファイル
    • BASF SE
    • Bayer AG
    • Abbott Laboratories
    • Stryker Corporation
    • Zimmer Biomet Holdings Inc.

第31章 その他の大手企業と革新的企業

  • Otsuka Medical Device Company Ltd.
  • LivaNova PLC
  • Ossur hf.
  • Forschungszentrum Julich GmbH
  • Biohorizons Implant Systems Inc.
  • Inventia Plc
  • Blatchford Limited
  • Keystone Dental Corporation
  • Xtant Medical Holdings Inc.
  • AVINENT Science and Technology
  • SynTouch Inc.
  • Curasan Inc.
  • CorNeat Vision Inc.
  • Hstar Technologies Co. Ltd.
  • Veryan Medical Ltd.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと潜在的な分析

第36章 付録

目次
Product Code: r16861

Medical biomimetics involves the creation and application of innovative technologies that mimic and enhance natural physiological processes. The goal is to develop functional and biomechanically optimized solutions in the healthcare field. Medical biomimetics plays a pivotal role in the advancement of artificial organs and tissues. Additionally, it is widely used in the design of drug delivery systems that replicate biological processes, thereby enhancing the precision and efficiency of targeted medication delivery.

The primary types of medical biomimetics encompass cardiovascular, orthopedic, ophthalmology, dental, and others. Cardiovascular medical biomimetics involves the examination and application of principles inspired by nature to create innovative solutions for medical challenges related to the heart and vascular system. These applications extend to areas such as wound healing, tissue engineering, drug delivery, and more. The end-users of cardiovascular medical biomimetics include hospitals, specialty clinics, and other healthcare facilities.

The medical biomimetics market research report is one of a series of new reports from The Business Research Company that provides medical biomimetics market statistics, including medical biomimetics industry global market size, regional shares, competitors with a medical biomimetics market share, detailed medical biomimetics market segments, market trends and opportunities, and any further data you may need to thrive in the medical biomimetics industry. This medical biomimetics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The medical biomimetics market size has grown strongly in recent years. It will grow from $33.8 billion in 2023 to $36.6 billion in 2024 at a compound annual growth rate (CAGR) of 8.2%. The expansion observed in the historical period can be attributed to various factors, including the increased utilization of biomimetic materials, higher research funding, a growing aging population, and an increase in the prevalence of chronic diseases. These factors collectively contributed to the development and adoption of medical biomimetics during that period.

The medical biomimetics market size is expected to see steady growth in the next few years. It will grow to $47.69 billion in 2028 at a compound annual growth rate (CAGR) of 6.8%. The anticipated growth in the forecast period is expected to be driven by factors such as the increasing demand for organ transplants, a growing awareness of biomimetics applications in healthcare, rising healthcare expenditure, the expansion of the biotechnology sector, and advancements in tissue engineering. Key trends in the forecast period encompass bio-inspired prosthetics, biomimetic sensors, applications of synthetic biology, smart drug delivery systems, biologically inspired robotics, personalized medicine, the utilization of 3D printing technologies, artificial intelligence in diagnostics, nanotechnology applications, and developments in regenerative medicine.

The anticipated rise in obesity and heart disease rates is expected to drive the growth of the medical biomimetics market. Obesity, characterized by the accumulation of excess body fat, and heart disease, encompassing various conditions affecting the heart and blood vessels, prompt the need for innovative solutions. Medical biomimetics plays a crucial role in developing assistive devices such as orthotics and prosthetics, catering to individuals managing conditions such as diabetes or obesity. In May 2022, the Centers for Disease Control and Prevention reported a significant increase in severe obesity in the US, reaching 9.2% in 2021 from 4.7%. Notably, adults aged 20 to 39 years had an obesity prevalence of 39.8%, while those aged 40 to 59 years had a prevalence of 44.3%. Additionally, a report from the UK's Office for National Statistics in March 2022 highlighted a rise in heart disease-related deaths from 19,440 in 2020 to 20,061 in 2021. The escalating rates of obesity and heart disease are therefore key drivers of the medical biomimetics market.

Leading companies in the medical biomimetics sector are strategically investing in innovative products equipped with advanced technologies. Notably, the development of a suture anchor system stands out as a significant advancement. This medical device, used in orthopedic and sports medicine procedures, secures soft tissues such as tendons or ligaments to bone. Suture anchor systems aim to mimic and enhance the natural attachment of soft tissues to bone, providing a biomechanically optimized solution mirroring physiological tissue connections. In December 2022, Stryker Corporation, a US-based multinational medical technologies company, launched Citrefix, a disposable suture anchor system incorporating a resorbable biomimetic anchor body made from Citregen, an elastomeric material engineered from a citrate polymer. This design facilitates controlled resorption without inducing chronic inflammation, making it a valuable tool in orthopedic surgical applications.

In September 2021, Keystone Dental Inc., a US-based dental implant company, strengthened its position by acquiring Osteon Medical, an Australia-based company specializing in medical biomimetics. The acquisition enables Keystone Dental to enhance its product portfolio by integrating Osteon's advanced scanning technology and cloud-based ordering platform, reinforcing its commitment to innovation in the dental implant sector.

Major companies operating in the medical biomimetics market report are BASF SE, Bayer AG, Abbott Laboratories, Stryker Corporation, Zimmer Biomet Holdings Inc., Otsuka Medical Device Company Ltd., LivaNova PLC, Ossur hf., Forschungszentrum Julich GmbH, Biohorizons Implant Systems Inc., Inventia Plc, Blatchford Limited, Keystone Dental Corporation, Xtant Medical Holdings Inc., AVINENT Science and Technology, SynTouch Inc., Curasan Inc., CorNeat Vision Inc., Hstar Technologies Co. Ltd., Veryan Medical Ltd., Swedish Biomimetics 3000 ApS, Osteopore International Pte Ltd., KitoTech Medical Ltd., Vandstrom Inc.

North America was the largest region in the medical biomimetics market in 2023. The regions covered in the medical biomimetics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the medical biomimetics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The medical biomimetics market consists of sales of diagnostic tools, wound healing products, bio-inspired robotics, bioelectronic devices and regenerative medicine. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from goods and/or services sold within the specified market and geography through sales, grants, or donations in terms of currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values - that is, they are revenues generated by organizations in the specified geography within the specified market, irrespective of where they are produced. It does not include revenues from resales either further along the supply chain or as part of other products.

Medical Biomimetics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on medical biomimetics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for medical biomimetics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The medical biomimetics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Cardiovascular; Orthopedic; Ophthalmology; Dental; Other Types
  • 2) By Application: Wound Healing; Tissue Engineering; Drug Delivery; Other Applications
  • 3) By End User: Hospitals; Specialty Clinics; Other End Users
  • Companies Mentioned: BASF SE; Bayer AG; Abbott Laboratories; Stryker Corporation; Zimmer Biomet Holdings Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Medical Biomimetics Market Characteristics

3. Medical Biomimetics Market Trends And Strategies

4. Medical Biomimetics Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Medical Biomimetics Market Size and Growth

  • 5.1. Global Medical Biomimetics Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Medical Biomimetics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Medical Biomimetics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Medical Biomimetics Market Segmentation

  • 6.1. Global Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Cardiovascular
  • Orthopedic
  • Ophthalmology
  • Dental
  • Other Types
  • 6.2. Global Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Wound Healing
  • Tissue Engineering
  • Drug Delivery
  • Other Applications
  • 6.3. Global Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Specialty Clinics
  • Other End Users

7. Medical Biomimetics Market Regional And Country Analysis

  • 7.1. Global Medical Biomimetics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Medical Biomimetics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Medical Biomimetics Market

  • 8.1. Asia-Pacific Medical Biomimetics Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Medical Biomimetics Market

  • 9.1. China Medical Biomimetics Market Overview
  • 9.2. China Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Medical Biomimetics Market

  • 10.1. India Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Medical Biomimetics Market

  • 11.1. Japan Medical Biomimetics Market Overview
  • 11.2. Japan Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Medical Biomimetics Market

  • 12.1. Australia Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Medical Biomimetics Market

  • 13.1. Indonesia Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Medical Biomimetics Market

  • 14.1. South Korea Medical Biomimetics Market Overview
  • 14.2. South Korea Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Medical Biomimetics Market

  • 15.1. Western Europe Medical Biomimetics Market Overview
  • 15.2. Western Europe Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Medical Biomimetics Market

  • 16.1. UK Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Medical Biomimetics Market

  • 17.1. Germany Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Medical Biomimetics Market

  • 18.1. France Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Medical Biomimetics Market

  • 19.1. Italy Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Medical Biomimetics Market

  • 20.1. Spain Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Medical Biomimetics Market

  • 21.1. Eastern Europe Medical Biomimetics Market Overview
  • 21.2. Eastern Europe Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Medical Biomimetics Market

  • 22.1. Russia Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Medical Biomimetics Market

  • 23.1. North America Medical Biomimetics Market Overview
  • 23.2. North America Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Medical Biomimetics Market

  • 24.1. USA Medical Biomimetics Market Overview
  • 24.2. USA Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Medical Biomimetics Market

  • 25.1. Canada Medical Biomimetics Market Overview
  • 25.2. Canada Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Medical Biomimetics Market

  • 26.1. South America Medical Biomimetics Market Overview
  • 26.2. South America Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Medical Biomimetics Market

  • 27.1. Brazil Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Medical Biomimetics Market

  • 28.1. Middle East Medical Biomimetics Market Overview
  • 28.2. Middle East Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Medical Biomimetics Market

  • 29.1. Africa Medical Biomimetics Market Overview
  • 29.2. Africa Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Medical Biomimetics Market Competitive Landscape And Company Profiles

  • 30.1. Medical Biomimetics Market Competitive Landscape
  • 30.2. Medical Biomimetics Market Company Profiles
    • 30.2.1. BASF SE
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Bayer AG
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Abbott Laboratories
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Stryker Corporation
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Zimmer Biomet Holdings Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Medical Biomimetics Market Other Major And Innovative Companies

  • 31.1. Otsuka Medical Device Company Ltd.
  • 31.2. LivaNova PLC
  • 31.3. Ossur hf.
  • 31.4. Forschungszentrum Julich GmbH
  • 31.5. Biohorizons Implant Systems Inc.
  • 31.6. Inventia Plc
  • 31.7. Blatchford Limited
  • 31.8. Keystone Dental Corporation
  • 31.9. Xtant Medical Holdings Inc.
  • 31.10. AVINENT Science and Technology
  • 31.11. SynTouch Inc.
  • 31.12. Curasan Inc.
  • 31.13. CorNeat Vision Inc.
  • 31.14. Hstar Technologies Co. Ltd.
  • 31.15. Veryan Medical Ltd.

32. Global Medical Biomimetics Market Competitive Benchmarking

33. Global Medical Biomimetics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Medical Biomimetics Market

35. Medical Biomimetics Market Future Outlook and Potential Analysis

  • 35.1 Medical Biomimetics Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Medical Biomimetics Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Medical Biomimetics Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer